CCL17 and pulmonary fibrosis: Since CCL17 can exhibit opposite effects on cells involved in lung fibrosis development, activating the TGF-β/Smad signaling pathway, and promoting fibroblast activation [23], the overall significance of Ccl17 overexpression remains unclear, and the presence of neutrophils in the spleen with increased expression of this cytokine requires further investigation.